A very early and acute renal impairment due to polyomavirus allograft nephropathy
2010; Wiley; Volume: 12; Issue: 6 Linguagem: Inglês
10.1111/j.1399-3062.2010.00536.x
ISSN1399-3062
AutoresGiorgia Comai, Gaetano La Manna, Giovanni Liviano D’Arcangelo, Francesca Centofanti, Chiara Valentini, Benedetta Fabbrizio, Regina Tardanico, G. Camaggi, Simona Venturoli, Maria Scolari, S. Stefoni,
Tópico(s)Parvovirus B19 Infection Studies
ResumoTransplant Infectious DiseaseVolume 12, Issue 6 p. 521-525 A very early and acute renal impairment due to polyomavirus allograft nephropathy G. Comai, G. Comai Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorG. La Manna, G. La Manna Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorG. Liviano D'Arcangelo, G. Liviano D'Arcangelo Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorF. Centofanti, F. Centofanti Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorC. Valentini, C. Valentini Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorB. Fabbrizio, B. Fabbrizio ’F. Addarii’ Institute of Oncologic and Transplantation Molecular Pathology, University of Bologna, Bologna, ItalySearch for more papers by this authorR. Tardanico, R. Tardanico Department of Pathology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this authorG. Camaggi, G. Camaggi ’F. Addarii’ Institute of Oncologic and Transplantation Molecular Pathology, University of Bologna, Bologna, ItalySearch for more papers by this authorS. Venturoli, S. Venturoli Department of Haematology and Oncological Sciences ‘L. A. Seragnoli,’ Microbiology Section, University of Bologna, Bologna, ItalySearch for more papers by this authorM.P. Scolari, M.P. Scolari Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorS. Stefoni, S. Stefoni Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this author G. Comai, G. Comai Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorG. La Manna, G. La Manna Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorG. Liviano D'Arcangelo, G. Liviano D'Arcangelo Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorF. Centofanti, F. Centofanti Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorC. Valentini, C. Valentini Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorB. Fabbrizio, B. Fabbrizio ’F. Addarii’ Institute of Oncologic and Transplantation Molecular Pathology, University of Bologna, Bologna, ItalySearch for more papers by this authorR. Tardanico, R. Tardanico Department of Pathology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this authorG. Camaggi, G. Camaggi ’F. Addarii’ Institute of Oncologic and Transplantation Molecular Pathology, University of Bologna, Bologna, ItalySearch for more papers by this authorS. Venturoli, S. Venturoli Department of Haematology and Oncological Sciences ‘L. A. Seragnoli,’ Microbiology Section, University of Bologna, Bologna, ItalySearch for more papers by this authorM.P. Scolari, M.P. Scolari Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this authorS. Stefoni, S. Stefoni Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, Bologna, ItalySearch for more papers by this author First published: 06 December 2010 https://doi.org/10.1111/j.1399-3062.2010.00536.x Gaetano La Manna, Department of Internal Medicine, Aging and Renal Disease, Section of Nephrology and Renal Transplant, University of Bologna, via Massarenti 9, 40138 Bologna, ItalyTel: +39 051 6364577Fax: +39 051 6363720E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Abstract G. Comai, G. La Manna, G. Liviano D'Arcangelo, F. Centofanti, C. Valentini, B. Fabbrizio, R. Tardanico, G. Camaggi, S. Venturoli, M.P. Scolari, S. Stefoni. A very early and acute renal impairment due to polyomavirus allograft nephropathy.Transpl Infect Dis 2010: 12: 521–525. All rights reserved Abstract: Polyomavirus-associated nephropathy (PVAN) has become an important cause of graft loss in the last few years. The typical course of PVAN is characterized by an asymptomatic period of viruria followed, within weeks, by the development of viremia in the context of stable renal function. The persistence of viral replication characterized by high viremia, leads to parenchymal injuries and causes the development, within months, of PVAN that could lead to deterioration in graft function and graft loss. We reported, in a patient who received a renal transplant, an unusual presentation of PVAN characterized by the development of acute renal failurte earlier than would be expected after transplantation, where the histological presentation alone could be confused with an acute rejection. We underline the importance of the association of histological findings with the viral load in urine and blood and with ancillary techniques such as immunohistochemistry and polymerase chain reaction (PCR) in situ for virus detection. We also want to emphasize that decoy cells and PCR for BK virus DNA research could be considered among the diagnostic tools for possible acute renal failure in kidney transplant. References 1 Wiseman AC. Polyomavirus nephropathy: a current perspective and clinical considerations. Am J Kidney Dis 2009; 54 (1): 131–142. PubMedWeb of Science®Google Scholar 2 El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9 (3): 527–535. 10.1111/j.1600-6143.2008.02519.x CASPubMedWeb of Science®Google Scholar 3 Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 2009; 87 (5): 621–630. PubMedWeb of Science®Google Scholar 4 Fischer SA. Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV. Transplantation 2008; 86 (10): 1327–1339. PubMedWeb of Science®Google Scholar 5 Nickeleit V, Mihatsch MJ. Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transpl Int 2006; 19 (12): 960–973. PubMedWeb of Science®Google Scholar 6 Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79 (10): 1277–1286. PubMedWeb of Science®Google Scholar 7 Rolla D, Giacomazzi CG, Gentile R, Ravetti JL, Cannella G, Varnier OE. Kidney graft loss associated with JC polyomavirus nephropathy. J Nephrol 2009; 22 (2): 295–298. PubMedWeb of Science®Google Scholar 8 Li RM, Mannon RB, Kleiner D, et al. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 2002; 74 (11): 1497–1504. 10.1097/00007890-200212150-00004 PubMedWeb of Science®Google Scholar 9 Jiang M, Abend JR, Johnson SF, Imperiale MJ. The role of polyomaviruses in human disease. Virology 2009; 384 (2): 266–273. 10.1016/j.virol.2008.09.027 CASPubMedWeb of Science®Google Scholar 10 Bohl DL, Storch GA, Ryshkewistch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213–2221. 10.1111/j.1600-6143.2005.01000.x CASPubMedWeb of Science®Google Scholar 11 Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int 2009; 22 (6): 626–634. PubMedWeb of Science®Google Scholar 12 Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68 (4): 1834–1839. PubMedWeb of Science®Google Scholar 13 Drachenberg CB, Papadimitriou JC. Polyomavirus-associated nephropathy: update in diagnosis. Transpl Infect Dis 2006; 8 (2): 68–75. CASPubMedWeb of Science®Google Scholar 14 Drachenberg CB, Papadimitriou JC, Ramos E. Histologic versus molecular diagnosis of BK polyomavirus-associated nephropathy: a shifting paradigm? Clin J Am Soc Nephrol 2006; 1 (3): 374–379. PubMedWeb of Science®Google Scholar 15 Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15 (3): 324–332. 10.1093/ndt/15.3.324 CASPubMedWeb of Science®Google Scholar 16 Nickeleit V, Hirsch HH, Binet IF. Polyomavirus infection of renal allografts recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10 (5): 1080–1089. CASPubMedWeb of Science®Google Scholar 17 Randhawa P, Shapiro R. Conceptual problems in the diagnosis and therapy of acute rejection in patients with polyomavirus nephropathy. Am J Transplant 2004; 4 (5): 840. 10.1111/j.1600-6143.2004.00466.x PubMedWeb of Science®Google Scholar 18 Alméras C, Foulongne V, Garrigue V, et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 2008; 85 (8): 1099–1104. 10.1097/TP.0b013e31816a33d4 PubMedWeb of Science®Google Scholar 19 Bonvoisin C, Weekers L, Xhignesse P, Grosch S, Milicevic M, Krzesinski JM. Polyomavirus in renal transplantation: a hot problem. Transplantation 2008; 85 (7): S42–S48. PubMedWeb of Science®Google Scholar 20 Hilton R, Tong CY. Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation. J Antimicrob Chemother 2008; 62 (5): 855–859. 10.1093/jac/dkn305 CASPubMedWeb of Science®Google Scholar Volume12, Issue6December 2010Pages 521-525 ReferencesRelatedInformation
Referência(s)